welcome to oneFAPvoice- a positively charged Familial Adenomatous Polyposis community.
- join today!
Coxib-inhibition of Duodenal Polyp Growth in FAP
study id #: NCT00844727
condition: Duodenal Polyposis
Preliminary data indicate a protective effect on the development of duodenal polyps by coxib treatment. The hypothesis of the present study is that normal therapy doses of rofecoxib for 1 year would stop or reverse the development of premalignant adenomatous lesions in the duodenal mucosa of FAP patients.
start date: September 2003
estimated completion: April 2004
last updated: July 6, 2011
phase of development: Phase 2, Phase 3
size / enrollment: 38
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
- FAP patient with previous colectomy and confirmed polyposis
- NSAID hypersensitivity
expertly curated content related to this topic
Familial Adenomatous Polyposis Associated with Gastrointestinal Stromal Tumor: Report of a CaseDesmoid tumors are one of the most commo...
Intraductal Papillary and Mucinous Pancreatic Tumour: A New Extracolonic Tumour in Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...
APC: The Key to Colon Cancer (The APC Protein and Its Role in Controlling the Cell Cycle)Poster Presentation Abstract: Colorec...
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)The purpose of this phase III study is t...
Surveillance and Treatment of Duodenal Adenomatosis in Familial Adenomatous PolyposisBACKGROUND AND STUDY AIMS : Patients wit...
Prostanoids, Ornithine Decarboxylase, and Polyamines in Primary Chemoprevention of Familial Adenomatous PolyposisBACKGROUND & AIMS : Familial adenoma...
Familial Adenomatous Polyposis (FAP) in 9 Hispanic WomenPoster Presentation Background: Famil...